Therapeutic Asset Ratings

753 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Advanced Ovarian High Grade Serous Adenocarcinoma	Mayo Clinic	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine FIGO Stage III Ovarian Cancer 2014	Mayo Clinic	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Mixed Cell Adenocarcinoma	Mayo Clinic	P2	B (60)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Hematopoietic and Lymphoid Cell Neoplasm	City of Hope Medical Center	P2	B (60)
Ny-Eso-1 Peptide Vaccine Ovarian Cancer Stage 3	Georgetown University	P2	B (60)
Personalized Neoantigen Peptide Vaccine Advanced NSCLC	The First Affiliated Hospital of Nanchang University	P2	B (60)
Personalized Neoantigen Peptide Vaccine Advanced Tumors	Seqker Biosciences, Inc.	P2	B (60)
Pumvc3-Igfbp2-Her2-Igf1R Plasmid Dna Vaccine Anatomic Stage I Breast Cancer AJCC v8	University of Washington	P2	B (60)
Ifx-Hu2.0 Merkel Cell Carcinoma	TuHURA Biosciences, Inc.	P2/3	B (60)
HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) Cirrhosis	Mahidol University	P4	B (59)
Ppsv23 Lymphoma, Non-Hodgkin	Poitiers University Hospital	P4	B (59)
Prevenar 13 Lymphoma, Non-Hodgkin	Poitiers University Hospital	P4	B (59)
Prevnar 20 Lymphoma, Non-Hodgkin	Poitiers University Hospital	P4	B (59)
9-valent human papillomavirus recombinant vaccine Anal Cancer	Xiamen University	P3	B (59)
Bacillus Calmette-Guerin High-risk Non-muscle Invasive Bladder Cancer	Merck Sharp & Dohme LLC	P3	B (59)
DIPHTHERIA TOXOID Multiple Sclerosis, Relapsing-Remitting	Celgene	P3	B (59)
Ppsv23 Multiple Sclerosis	Celgene	P3	B (59)
Dpx-Survivac Epithelial Ovarian Cancer	ImmunoVaccine Technologies, Inc. (IMV Inc.)	P2	B (59)
Gvax Pancreas Vaccine Pancreatic Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	B (59)
Galinpepimut-S Acute Myeloid Leukemia	Sellas Life Sciences Group	P3	B (58)
Aadvac1 Alzheimer's Disease	Paul S. Aisen	P2	B (58)
bnt116 Advanced Non-Small Cell Lung Cancer	Regeneron Pharmaceuticals	P2	B (58)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine Anatomic Stage IV Breast Cancer AJCC v8	University of Washington	P2	B (58)
Dc/Aml Fusion Vaccine Acute Myelogenous Leukemia	David Avigan	P2	B (58)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Recurrent Fallopian Tube Carcinoma	City of Hope Medical Center	P2	B (58)

Showing 76 to 100 of 753 assets

PreviousPage 4 of 31Next